Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nonaka

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Basic studies of intra-arterial hyperthermic treatment]T Maeda, S Kuramoto, Y Shimojima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1984
[Low-dose cytosine arabinoside (Ara-C) continuous infusion regimen for atypical nonlymphocytic leukemia--clinical study of the remission mechanism by serial chromosomal findings, colony formation and plasma Ara-C concentration]M Tagawa, M Tomonaga, J Shibata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1989
[Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation]M Tomonaga, I Jinnai, K Kuriyama, et al.
The American Journal of Physiology|February 1, 1992
Muscarinic receptor subtypes in feline tracheal submucosal gland secretionH Ishihara, S Shimura, M Satoh, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 9, 1999
Increased urinary levels of adrenomedullin in patients with cystitisY Nishitani, A Kubo, Y Kaneko, et al.
Leukemia Research|January 4, 2001
De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapyS Yoshida, K Kuriyama, Y Miyazaki, et al.
Neurology|December 10, 2003
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's diseaseHiroshi Kase, S Aoyama, M Ichimura, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Basic studies of intra-arterial hyperthermic treatment]T Maeda, S Kuramoto, Y Shimojima, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1984
[Low-dose cytosine arabinoside (Ara-C) continuous infusion regimen for atypical nonlymphocytic leukemia--clinical study of the remission mechanism by serial chromosomal findings, colony formation and plasma Ara-C concentration]M Tagawa, M Tomonaga, J Shibata, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 1, 1989
[Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation]M Tomonaga, I Jinnai, K Kuriyama, et al.
The American Journal of Physiology|February 1, 1992
Muscarinic receptor subtypes in feline tracheal submucosal gland secretionH Ishihara, S Shimura, M Satoh, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 9, 1999
Increased urinary levels of adrenomedullin in patients with cystitisY Nishitani, A Kubo, Y Kaneko, et al.
Leukemia Research|January 4, 2001
De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapyS Yoshida, K Kuriyama, Y Miyazaki, et al.
Neurology|December 10, 2003
Progress in pursuit of therapeutic A2A antagonists: the adenosine A2A receptor selective antagonist KW6002: research and development toward a novel nondopaminergic therapy for Parkinson's diseaseHiroshi Kase, S Aoyama, M Ichimura, et al.
Pageof 15